3Stratton IM,Adler AI,Neil HA,ei al. Association of glycemia with macro-vascular and microvascular complications of type 2( UKPDS 35) : diabe-tes :prospective observational study[ J]. BMJ,2000;321 (12) ;405-12.
4Klein R,Klein BE,Moss SE. Relation of glycemic control to diabetic mi-crovascular complications in diabetes mellitus[J]. Ann Intern Med,1996 ; 124 (lPt2) :90-6.
4Amemiya S, Kato K, Asayama K. The improved response in endogenous insulin due to continuous subcutaneous infusion of insulin therapy in juvenile diabetes. Tohoku J Exp Med, 1983,141 (Suppl) :713-717.
5Garvey WT, Olefsky JM, Griffin J, et al. The effect of insulin treatment on insulin secretion and insulin action in type Ⅱ diabetes mellitus. Diabetes, 1985,34:222-234.
6Glaser B, Leibovich G, Nesher R, et al. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinol, 1988,118:365-373.
7llkova H, Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20 : 1353-1356.
8Yoshioka K, Yoshida T, Yoshikawa T. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes: response to Ryan, lmes,and Wallace. Diabetes Care, 2004,27:2281-2282.
9Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of B-cell function. Diabetes Care, 2004,27:2597-2602.
10Rasouli N, Elbein SC. Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab, 2004,89 : 6331 -6335.
5Del Prato S, Felton AM, Muntro N, et al. Improving glucose management: ten steps to get more patients with type 2 diabe tes to glycaemic goal [J]. Int J Clin Pract, 2005, 59 (11): 1345-1355.
6Stratton IM, Adler AI, Neil HA, et al. Association of glyce- mla with macrovascular and micmvascular complications of type 2 (UKPDS 35) :diabetes: prospective observational study [J]. BMJ, 2000, 321(12): 405-412.
7Klein R, Klein BE, Moss SE. Relation of glycemic control to diabetic micmvascular complications in diabetes mellitus[J]. Ann Intern Med, 1996, 124(IPt2): 90-96.
8Korytkowski M, Thomas A, Reid L, et al. Glimepiride im- proves both first and second phases of insulin secretion in type2 diabetes[J]. Diabetes Care, 2002,25 : 1607-1611.
9Arai K, Matoba K, Hirao K, etal. Present status of sulfony lurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15652 patients[J]. Endocr J, 2010, 57(6) : 499-507.
10Arai K,Matoba K,Hirao K,et al.Present status of sulfonylurea treatment for type 2 diabetes in Japan:second report of a cross-sectional survey of 15652 patients.Endocr J,2010,57:499-507.
